The name Monsanto is headed for retirement. Bayer has confirmed it will no longer use the name after it closes its US$63 billion acquisition of Monsanto. Monsanto has been the target of anti-GMO activists for years, serving as a corporate lightning rod for critics of genetic modification and crop protection technology in general. Whether referenced… Read More
Tag: Monsanto
One of the most well-known and controversial brands in the world will soon become part of history. Bayer has confirmed it plans to complete its acquisition of Monsanto on June 7, after receiving all the required regulatory approvals. Monsanto products will retain their brand names under Bayer’s portfolio, but the name “Monsanto” will be retired…. Read More
Canada’s competition regulator says it has reached an agreement with Bayer that lays out the conditions for its proposed acquisition of Monsanto. The announcement comes a day after the U.S. Department of Justice gave its conditional approval to the US$66 billion deal. The Competition Bureau concluded that the deal “would likely substantially lessen and prevent… Read More
With the European Union granting its conditional approval in late March, and U.S. antitrust authorities reportedly set to give their thumbs-up signal, Canada’s competition regulator has yet to issue its decision on Bayer’s proposed acquisition of Monsanto. The US$66 billion deal, which was originally announced in September 2016, has significant implications in the Canadian market,… Read More
The third year of Monsanto BioAg’s BioAdvantage Trials (BAT) wrapped up with a morning event that had co-operators, agronomists, and reps feeling optimistic for the growing season to come. The event was held in Saskatoon, the home of partner brand Novozymes’ headquarters and a hub for Western Canadian Ag. The event would update attendees on… Read More
Bayer has confirmed it will be selling its digital farming business to gain approval of its acquisition of Monsanto instead of licensing the digital assets out to a competing company. In gaining regulatory approval of the deal in Europe, Bayer had agreed to license its digital farming package to BASF. However, in a statement shared… Read More
Bayer has checked off one of the final boxes on the list of approvals needed for its acquisition of Monsanto, as the European Commission granted conditional approval of the $66 billion deal on Wednesday. “We have approved Bayer’s plans to take over Monsanto because the parties’ remedies, worth well over €6 billion, meet our competition… Read More
Monsanto plans to expand its Xtend herbicide tolerance package, which combines tolerance to dicamba and glyphosate, in the coming years, adding other herbicide-tolerance traits, and introducing it to new crops, including canola. Monsanto, subsidiary The Climate Corporation, and The BioAg Alliance — Monsanto’s collaboration with Novozymes — shared their annual innovation pipeline updates in conjunction… Read More
Bayer has signed an agreement to divest some of its crop business to BASF for €5.9 billion (approximately C$8.7 billion) to gain regulatory approval for Bayer’s planned acquisition of Monsanto. The transaction with BASF includes Bayer’s global glufosinate-ammonium business and the related LibertyLink herbicide tolerance technology. BASF is also marking its entry into the seed… Read More
In order to get the $66 billion purchase of Monsanto finalized, Bayer has agreed to sell its LibertyLink trait and herbicide portfolio, according to Reuters. The Competition Commission of South Africa announced the stipulation earlier this week, to which Bayer has reportedly agreed. The divestiture of some traits doesn’t come as a surprise to most, with… Read More